Bank Pictet & Cie (Europe)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,562	Closed	-$383K	–	155
2024 Q1	$383K	Buy	2,562 +835	+48%	+$125K	0.01%	139
2023 Q4	$331K	Sell	1,727 -63	-4%	-$12.1K	0.01%	222
2023 Q3	$317K	Sell	1,790 -23	-1%	-$4.07K	0.01%	214
2023 Q2	$344K	Buy	+1,813	New	+$344K	0.01%	212